Optimal utilization of thrombophilia testing
نویسندگان
چکیده
منابع مشابه
The futility of thrombophilia testing.
There has been increasing recognition of various laboratory markers of thrombophilia that are associated with increased risk of thrombosis either through hereditary (especially Factor V Leiden, prothrombin G20210A mutation, and protein C, S and antithrombin deficiencies) and/or acquired means (e.g., antiphospholipid antibodies) over past decades. This has led to an explosion of clinical request...
متن کاملIs thrombophilia testing useful?
Thrombophilia is found in many patients presenting with venous thromboembolism (VTE). However, whether the results of such tests help in the clinical management of such patients has not been determined. Thrombophilia testing in asymptomatic relatives may be useful in families with antithrombin, protein C, or protein S deficiency or homozygosity for factor V Leiden, but is limited to women who i...
متن کاملThe utility of thrombophilia testing.
In the past decades, the recognition of several inherited thrombophilic traits has greatly improved our knowledge of the pathogenesis of venous thromboembolism, explaining about half of all idiopathic cases. As a consequence, thrombophilia testing has enormously increased in the past years for various clinical conditions. In this paper, the current indications of the most commonly tested thromb...
متن کاملTesting for thrombophilia: clinical update.
British Journal of General Practice, February 2014 e120 baCKGROUND Thrombophilia describes inherited and acquired prothrombotic states which predispose to venous, but not arterial thromboembolism. The heritable states are of limited clinical significance in primary care and while they may underlie a patient’s presentation with deep venous thrombosis (DVT) or pulmonary embolism (PE) of uncertain...
متن کاملPsychotropic Medications: Optimal Prescribing Through the Utilization of Genetic Testing
Psychiatric drug treatment is characterized by large interindividual differences in drug response and dosage requirements. For example, only half of the patients will respond to antidepressant treatment and only one-third of patients experience a full remission of symptoms [1]. In terms of antipsychotic medication, approximately 20% to 35% of people affected by schizophrenia, under optimal anti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Laboratory Hematology
سال: 2017
ISSN: 1751-5521
DOI: 10.1111/ijlh.12672